BioMarin Pharmaceutical Japan

I couldn't find specific information about "BioMarin Pharmaceutical Japan." However, BioMarin Pharmaceutical is a global biotechnology company with a focus on developing and commercializing innovative therapies for patients with rare genetic diseases. The company's portfolio includes drugs for rare genetic disorders such as phenylketonuria (PKU), Batten disease, hemophilia, and various forms of inherited metabolic disorders. BioMarin has been a leader in the development of enzyme replacement and gene therapy treatments for these conditions. The company was founded in 1997 and continues to invest in research and development to address the unmet medical needs of individuals with rare diseases.